Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:10 Issue:1 Number:20 ISSN#:2563-5476
RCT
ACE Report #12935
Ace Report Cover Spine

Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis


How to Cite

OrthoEvidence. Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis. ACE Report. 2021;10(1):20. Available from: https://myorthoevidene.com/AceReport/Report/12935

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial

Int J Rehabil Res. 2020 Dec;43(4):342-346.

Contributing Authors: H Akbari Aghdam A Andalib H Asadiyan Ardakani M Telloo E Sheikhbahaei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-three patients with refractory lumbar spinal stenosis (LSS) were randomized to receive 1 week of oral corticosteroid (prednisolone; n=47) or a placebo (n=46) for the improvement of functionality and relief of pain. The primary outcomes of interest was the improvement in walking distance and Oswestry Disability Index (ODI). The secondary outcomes of interest was pain score on a Numeric Ratin...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE